Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Nirmal Shaji George: Individualizing Anticoagulation in Complex APS and Thrombocytopenia
Nirmal Shaji George/LinkedIn, Ansu Cheriyan/LinkedIn
Oct 4, 2026, 13:53

Nirmal Shaji George: Individualizing Anticoagulation in Complex APS and Thrombocytopenia

Nirmal Shaji George, Doctor of Pharmacy – PharmD at Nazareth College of Pharmacy, Othera, Tiruvalla, shared a post on LinkedIn:

“How do you manage thrombosis risk when a patient’s platelet count is dangerously low?

As part of my 4th-year Pharm.D clinical training, I recently worked on a case involving antiphospholipid syndrome (APS) complicated by severe thrombocytopenia – a challenging intersection of thrombosis and bleeding risk.

APS is an autoimmune, hypercoagulable disorder associated with antiphospholipid antibodies such as lupus anticoagulant, anticardiolipin, and anti-β2 glycoprotein I antibodies.

While thrombosis and pregnancy morbidity form the major clinical criteria, thrombocytopenia is a recognized non-criteria manifestation of APS.

What made this case particularly valuable was the therapeutic dilemma: a patient with a strong thrombotic risk, but also an extremely low platelet count.

Anticoagulation therefore cannot be viewed simply as ‘preventing clots’ – the timing, intensity, bleeding risk, platelet recovery, and overall clinical context all matter.

From a clinical pharmacy perspective, the case highlighted the importance of:

  • Reviewing anticoagulation strategies according to the patient’s APS risk profile.
  • Identifying drug–drug interactions and therapy-related risks.
  • Monitoring platelet counts, bleeding, and thrombotic events.
  • Providing clear patient counselling regarding adherence and warning signs.

Clinical pearl: APS can present with both thrombotic complications and thrombocytopenia, making individualized pharmacotherapy essential.

This case reinforced for me that clinical pharmacy is not just about knowing the drug – it is about understanding the disease, the patient, and the balance between competing risks.

I’d be glad to connect with others interested in clinical pharmacy, anticoagulation, and Pharm.D practice.”

Nirmal Shaji George, Ansu Cheriyan

Stay updated with Hemostasis Today.

Ansu Cheriyan Anti-β2 glycoprotein I anticardiolipin Antiphospholipid Syndrome APS Health Hematology Hemostasis Hemostasis News Hemostasis Today Lupus Anticoagulant Medicine Nirmal Shaji George platelets Rheumatology thrombosis
NewsFeed